Abstract
Multidrug resistance protein 8 (ABCC11) is an efflux transporter for anionic lipophilic compounds, conferring resistance to antiviral and anticancer agents like 5-fluorouracil (5-FU). ABCC11 missense variants may contribute to variability in drug response but functional consequences, except for the ‘earwax variant’ c.538G>A, are unknown. Using the ‘Screen and Insert’ technology, we generated human embryonic kidney 293 cells stably expressing ABCC11 missense variants frequently occurring in different ethnic populations: c.57G>A, c.538G>A, c.950C>A, c.1637C>T, c.1942G>A, c.4032A>G. A series of in silico prediction analyses and in vitro plasma membrane vesicle uptake, immunoblotting and immunolocalization experiments were undertaken to investigate functional consequences. We identified c.1637C>T (T546M), previously associated with 5-FU-related toxicity, as a novel functionally damaging ABCC11 variant exhibiting markedly reduced transport function of 5-FdUMP, the active cytotoxic metabolite of 5-FU. Detailed analysis of 14 subpopulations revealed highest allele frequencies of c.1637C>T in Europeans and Americans (up to 11%) compared with Africans and Asians (up to 3%).
Similar content being viewed by others
Accession codes
References
Meyer UA, Zanger UM, Schwab M . Omics and Drug Response. Annu Rev Pharmacol Toxicol 2013; 53: 475–502.
Wang L, McLeod HL, Weinshilboum RM . Genomics and drug response. N Engl J Med 2011; 364: 1144–1153.
Giacomini KM, Huang SM, Tweedie DJ, Benet LZ, Brouwer KL, Chu X et al. Membrane transporters in drug development. Nat Rev Drug Discov 2010; 9: 215–236.
Schuetz JD, Swaan PW, Tweedie DJ . The role of transporters in toxicity and disease. Drug Metab Dispos 2014; 42: 541–545.
Errasti-Murugarren E, Pastor-Anglada M . Drug transporter pharmacogenetics in nucleoside-based therapies. Pharmacogenomics 2010; 11: 809–841.
Slot AJ, Molinski SV, Cole SP . Mammalian multidrug-resistance proteins (MRPs). Essays Biochem 2011; 50: 179–207.
Nies AT, Lang T . Multidrug resistance proteins of the ABCC subfamily. In: You G, Morris ME (eds). Drug Transporters: Molecular Characterization and Role in Drug Disposition, 2 edn. John Wiley & Sons: Hoboken, 2014, pp 161–185.
Guo Y, Kotova E, Chen ZS, Lee K, Hopper-Borge E, Belinsky MG et al. MRP8, ATP-binding cassette C11 (ABCC11), is a cyclic nucleotide efflux pump and a resistance factor for fluoropyrimidines 2',3'-dideoxycytidine and 9'-(2'-phosphonylmethoxyethyl)adenine. J Biol Chem 2003; 278: 29509–29514.
Toyoda Y, Ishikawa T . Pharmacogenomics of human ABC transporter ABCC11 (MRP8): potential risk of breast cancer and chemotherapy failure. Anticancer Agents Med Chem 2010; 10: 617–624.
Chen ZS, Guo Y, Belinsky MG, Kotova E, Kruh GD . Transport of bile acids, sulfated steroids, estradiol 17-beta-D-glucuronide, and leukotriene C4 by human multidrug resistance protein 8 (ABCC11). Mol Pharmacol 2005; 67: 545–557.
Bortfeld M, Rius M, König J, Herold-Mende C, Nies AT, Keppler D . Human multidrug resistance protein ABCC11 (MRP8), an apical efflux pump for steroid sulfates, is an axonal protein of the central and peripheral nervous system. Neuroscience 2006; 137: 1247–1257.
Baumann T, Bergmann S, Schmidt-Rose T, Max H, Martin A, Enthaler B et al. Glutathione-conjugated sulfanylalkanols are substrates for ABCC11 and gamma-glutamyl transferase 1: a potential new pathway for the formation of odorant precursors in the apocrine sweat gland. Exp Dermatol 2014; 23: 247–252.
Bera TK, Lee S, Salvatore G, Lee B, Pastan I . MRP8, a new member of ABC transporter superfamily, identified by EST database mining and gene prediction program, is highly expressed in breast cancer. Mol Med 2001; 7: 509–516.
Tammur J, Prades C, Arnould I, Rzhetsky A, Hutchinson A, Adachi M et al. Two new genes from the human ATP-binding cassette transporter superfamily, ABCC11 and ABCC12, tandemly duplicated on chromosome 16q12. Gene 2001; 273: 89–96.
Yabuuchi H, Shimizu H, Takayanagi S, Ishikawa T . Multiple splicing variants of two new human ATP-binding cassette transporters, ABCC11 and ABCC12. Biochem Biophys Res Commun 2001; 288: 933–939.
Matsson P, Yee SW, Markova S, Morrissey K, Jenkins G, Xuan J et al. Discovery of regulatory elements in human ATP-binding cassette transporters through expression quantitative trait mapping. Pharmacogenomics J 2012; 12: 214–226.
Toyoda Y, Sakurai A, Mitani Y, Nakashima M, Yoshiura K, Nakagawa H et al. Earwax, osmidrosis, and breast cancer: why does one SNP (538G>A) in the human ABC transporter ABCC11 gene determine earwax type? FASEB J 2009; 23: 2001–2013.
Yoshiura K, Kinoshita A, Ishida T, Ninokata A, Ishikawa T, Kaname T et al. A SNP in the ABCC11 gene is the determinant of human earwax type. Nat Genet 2006; 38: 324–330.
Ishikawa T, Toyoda Y, Yoshiura K, Niikawa N . Pharmacogenetics of human ABC transporter ABCC11: new insights into apocrine gland growth and metabolite secretion. Front Genet 2013; 3: 306.
Magdy T, Arlanov R, Winter S, Lang T, Klein K, Toyoda Y et al. ABCC11/MRP8 polymorphisms affect 5-fluorouracil-induced severe toxicity and hepatic expression. Pharmacogenomics 2013; 14: 1433–1448.
Shimizu H, Taniguchi H, Hippo Y, Hayashizaki Y, Aburatani H, Ishikawa T . Characterization of the mouse Abcc12 gene and its transcript encoding an ATP-binding cassette transporter, an orthologue of human ABCC12. Gene 2003; 310: 17–28.
Arlanov R, Porter A, Strand D, Brough R, Karpova D, Kerb R et al. Functional characterization of protein variants of the human multidrug transporter ABCC2 by a novel targeted expression system in fibrosarcoma cells. Hum Mutat 2012; 33: 750–762.
Keppler D, Jedlitschky G, Leier I . Transport function and substrate specificity of multidrug resistance protein. Methods Enzymol 1998; 292: 607–616.
Keitel V, Kartenbeck J, Nies AT, Spring H, Brom M, Keppler D . Impaired protein maturation of the conjugate export pump multidrug resistance protein 2 as a consequence of a deletion mutation in Dubin-Johnson syndrome. Hepatology 2000; 32: 1317–1328.
Rädisch S, Dickens D, Lang T, Bonnett L, Arlanov R, Johnson MR et al. A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine. Pharmacogenomics J 2014; 14: 481–487.
Linton KJ, Higgins CF . Structure and function of ABC transporters: the ATP switch provides flexible control. Pflugers Arch 2007; 453: 555–567.
Sarkadi B, Price EM, Boucher RC, Germann UA, Scarborough GA . Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J Biol Chem 1992; 267: 4854–4858.
Ramsey LB, Bruun GH, Yang W, Trevino LR, Vattathil S, Scheet P et al. Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Res 2012; 22: 1–8.
Nies AT, Niemi M, Burk O, Winter S, Zanger UM, Stieger B et al. Genetics is a major determinant of expression of the human hepatic uptake transporter OATP1B1, but not of OATP1B3 and OATP2B1. Genome Med 2013; 5: 1.
Nies AT, Magdy T, Schwab M, Zanger UM . Role of ABC transporters in fluoropyrimidine-based chemotherapy response. Adv Cancer Res 2015; 125: 217–243.
Reid G, Wielinga P, Zelcer N, van der Heijden I, Kuil A, de Haas M et al. The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs. Proc Natl Acad Sci USA 2003; 100: 9244–9249.
Gao M, Cui HR, Loe DW, Grant CE, Almquist KC, Cole SP et al. Comparison of the functional characteristics of the nucleotide binding domains of multidrug resistance protein 1. J Biol Chem 2000; 275: 13098–13108.
Radloff R, Gras A, Zanger UM, Masquelier C, Arumugam K, Karasi JC et al. Novel CYP2B6 enzyme variants in a Rwandese population: functional characterization and assessment of in silico prediction tools. Hum Mutat 2013; 34: 725–734.
Oguri T, Bessho Y, Achiwa H, Ozasa H, Maeno K, Maeda H et al. MRP8/ABCC11 directly confers resistance to 5-fluorouracil. Mol Cancer Ther 2007; 6: 122–127.
Acknowledgements
We gratefully acknowledge Sabine Rekersbrink and Silvia Hübner for expert technical assistance. RA, TL, ES, MS and ATN were supported by the Robert Bosch Stiftung, Stuttgart, Germany, RA and TL were supported by the German Research Foundation DFG (LA 2406/2-1). GJ was supported by the German Research Foundation DFG (JE 234/4-1). ATN and MS were supported by the 7FP EU Initial Training Network program‚ FightingDrugFailure’ (GA-2009–238132). MS and ES were supported in part by the Federal Ministry for Education and Research (BMBF, Berlin, Germany; grant 03 IS 2061C and 0315755).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the The Pharmacogenomics Journal website
Supplementary information
Rights and permissions
About this article
Cite this article
Arlanov, R., Lang, T., Jedlitschky, G. et al. Functional characterization of common protein variants in the efflux transporter ABCC11 and identification of T546M as functionally damaging variant. Pharmacogenomics J 16, 193–201 (2016). https://doi.org/10.1038/tpj.2015.27
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/tpj.2015.27
- Springer Nature Limited
This article is cited by
-
MicroRNAs and drug resistance in colorectal cancer with special focus on 5-fluorouracil
Molecular Biology Reports (2022)
-
The impact of ABCC11 polymorphisms on the risk of early-onset fluoropyrimidine toxicity
The Pharmacogenomics Journal (2017)
-
Protein expression of ATP-binding cassette transporters ABCC10 and ABCC11 associates with survival of colorectal cancer patients
Cancer Chemotherapy and Pharmacology (2016)